CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Common Stock [Member] Net Cumulative Effect from Adoption [Member]	[1]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Net Cumulative Effect from Adoption [Member]	[1]	Retained Earnings [Member]	Retained Earnings [Member] Net Cumulative Effect from Adoption [Member]	[1]	Accumulated Other Comprehensive Loss [Member]	Accumulated Other Comprehensive Loss [Member] Net Cumulative Effect from Adoption [Member]	[1]	Total	Net Cumulative Effect from Adoption [Member]	[1]
BALANCE at Dec. 31, 2022	$ 49,072			$ 45,540			$ 51,225			$ (960)			$ 144,877
BALANCE (in shares) at Dec. 31, 2022	31,147,925
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]													Accounting Standards Update 2016-13 [Member]
Net (loss) income	$ 0			0			(109)			0			$ (109)
Employee pension plan adjustments	0			0			0			(48)			(48)
Stock-based compensation expense
Restricted stock	$ 0			812			0			0			812
Restricted stock (in shares)	652,042
Share repurchase	$ (556)			0			0			0			(556)
Share repurchase (in shares)	(104,030)
Net share settlement for equity-based compensation	$ 0			(1,779)			0			0			(1,779)
Net share settlement for equity-based compensation (in shares)	(297,380)
BALANCE at Mar. 31, 2023	$ 48,516	$ 0		44,573	$ 0		43,173	$ (7,943)		(1,008)	$ 0		135,254	$ (7,943)
BALANCE (in shares) at Mar. 31, 2023	31,398,557	0
BALANCE at Dec. 31, 2022	$ 49,072			45,540			51,225			(960)			144,877
BALANCE (in shares) at Dec. 31, 2022	31,147,925
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income													17,141
BALANCE at Jun. 30, 2023	$ 48,181			46,874			60,423			(1,013)			154,465
BALANCE (in shares) at Jun. 30, 2023	31,359,110
BALANCE at Mar. 31, 2023	$ 48,516	$ 0		44,573	$ 0		43,173	$ (7,943)		(1,008)	$ 0		135,254	$ (7,943)
BALANCE (in shares) at Mar. 31, 2023	31,398,557	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 0			0			17,250			0			17,250
Employee pension plan adjustments	0			0			0			(5)			(5)
Stock-based compensation expense
Restricted stock	$ 0			2,576			0			0			2,576
Restricted stock (in shares)	61,257
Share repurchase	$ (335)			0			0			0			(335)
Share repurchase (in shares)	(61,034)
Net share settlement for equity-based compensation	$ 0			(275)			0			0			(275)
Net share settlement for equity-based compensation (in shares)	(39,670)
BALANCE at Jun. 30, 2023	$ 48,181			46,874			60,423			(1,013)			154,465
BALANCE (in shares) at Jun. 30, 2023	31,359,110
BALANCE at Dec. 31, 2023	$ 48,181			49,380			69,279			(36)			166,804
BALANCE (in shares) at Dec. 31, 2023	31,359,110
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 0			0			(214)			0			(214)
Stock-based compensation expense
Restricted stock	$ 0			1,059			0			0			1,059
Restricted stock (in shares)	400,212
Net share settlement for equity-based compensation	$ 0			(3,156)			0			0			(3,156)
Net share settlement for equity-based compensation (in shares)	(315,611)
BALANCE at Mar. 31, 2024	$ 48,181			47,283			69,065			(36)			164,493
BALANCE (in shares) at Mar. 31, 2024	31,443,711
BALANCE at Dec. 31, 2023	$ 48,181			49,380			69,279			(36)			166,804
BALANCE (in shares) at Dec. 31, 2023	31,359,110
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income													(896)
BALANCE at Jun. 30, 2024	$ 48,181			48,328			68,383			(36)			164,856
BALANCE (in shares) at Jun. 30, 2024	31,490,839
BALANCE at Mar. 31, 2024	$ 48,181			47,283			69,065			(36)			164,493
BALANCE (in shares) at Mar. 31, 2024	31,443,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 0			0			(682)			0			(682)
Stock-based compensation expense
Restricted stock	$ 0			1,045			0			0			1,045
Restricted stock (in shares)	47,128
BALANCE at Jun. 30, 2024	$ 48,181			$ 48,328			$ 68,383			$ (36)			$ 164,856
BALANCE (in shares) at Jun. 30, 2024	31,490,839

[1] Net cumulative adjustment to equity based on the adoption of Accounting Standards Update No. 2016-13 Financial Instruments-Credit Losses.  See Note 12 to the Condensed Consolidated Financial Statements.